ABSTRACT
Las demoliciones, construcciones y/o remodelaciones pueden provocar infecciones intrahospitalarias en pacientes con factores de riesgos, especialmente aspergilosis pulmonar. En la presente guia se describen algunas medidas que pueden ayudar a mitigar estas infecciones en los distintos recintos hospitalarios.
Demolitions, constructions and renovations can produce nosocomial infections in patients with risk factors, specially lung aspergillosis. The following guide describes some actions that could help in the mitigation of these infections in the different hospitals.
Subject(s)
Humans , Aspergillus/pathogenicity , Pulmonary Aspergillosis/etiology , Pulmonary Aspergillosis/prevention & control , Immunocompromised Host , Infection Control , Cross Infection/etiology , Cross Infection/prevention & control , Construction Wastes , Fungi/pathogenicity , Opportunistic Infections , Sanitary SpecificationsABSTRACT
Endobronchial spillage of fungal material into normal lung can infect it and the spillage of fungal material should be prevented during surgery. We report our experience of a patient who presented for right upper lobectomy with bronchiectasis, tubercular destruction and subsequent aspergilloma. A 4F Fogarty catheter was introduced through the tracheal lumen of the left sided endobronchial double lumen tube (DLT) to occlude the bronchus intermedius to prevent spillage of aspergilloma into the non‑infected lower and middle lobes of the right lung. The Fogarty catheter was pulled into the trachea just before stapling the bronchus; thereafter, right upper lobectomy was completed successfully. The patient was extubated uneventfully and transferred to post‑operative recovery ward. The endobronchial blockage of the intermediate bronchus of the operative lung by the Fogarty catheter and isolation of the left lung by the DLT prevented spillage of aspergilloma in both the operative right lung and the left lung.
Subject(s)
Adult , Catheters/instrumentation , Catheters/methods , Female , Humans , Pulmonary Aspergillosis/prevention & control , Pulmonary Aspergillosis/therapy , Thoracic Surgery, Video-Assisted/methodsABSTRACT
Background: Systemic fungal infections and specifically invasive aspergillosis (IA) are associated with a high morbi-mortality rate in patients with hematologic malignancies. Itraconazole kinetic studies show that plasma levels are not satisfactory, even though there is a reduction of the severity in clinical cases. Aim: To evaluate the results of oral prophylaxis with high dose itraconazole, 400 mg bid, among patients with adult acute leukemia. Material and Methods: Prospective analysis of 93 high risk febrile episodes (with an absolute neutrophil count of less than 500 x mm3 for more 10 days), that occurred in 76 patients. Results: Seventy five percent of episodes occurred in patients with acute myeloid leukemia and 25 percent in patients with acute lymphoblastic leukemia. Fifty two percent occurred during the induction of chemotherapy. Median duration of severe neutropenia was 21 days (range 10-48). Median duration of itraconazole prophylaxis was 17 days (range 6-34). A low frequency of invasive fungal infections was observed (17 percent). According to diagnostic criteria, 5 percent of episodes corresponded to persistent fever , 1 percent and 11 percent of episodes, to probable or possible IA, respectively. No confirmed or proven IA was observed. Mortality of IA was 18 percent. No serious adverse events due to itraconazole were observed. Conclusions: The use of high dose itraconazole prophylaxis in adult patients with acute leukemia and severe neutropenia was associated to low incidence and mortality of invasive mycoses.